[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2003054215A3 - Therapeutic protein and nucleic acid - Google Patents

Therapeutic protein and nucleic acid Download PDF

Info

Publication number
WO2003054215A3
WO2003054215A3 PCT/US2002/039543 US0239543W WO03054215A3 WO 2003054215 A3 WO2003054215 A3 WO 2003054215A3 US 0239543 W US0239543 W US 0239543W WO 03054215 A3 WO03054215 A3 WO 03054215A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
therapeutic protein
fragments
activity
protein
Prior art date
Application number
PCT/US2002/039543
Other languages
French (fr)
Other versions
WO2003054215A2 (en
Inventor
Shih Hsin Lu
Original Assignee
Cancer Inst Of The Chinese Aca
Nat Foundation For Cancer Res
Shih Hsin Lu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Inst Of The Chinese Aca, Nat Foundation For Cancer Res, Shih Hsin Lu filed Critical Cancer Inst Of The Chinese Aca
Priority to AU2002357145A priority Critical patent/AU2002357145A1/en
Publication of WO2003054215A2 publication Critical patent/WO2003054215A2/en
Publication of WO2003054215A3 publication Critical patent/WO2003054215A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A previously unidentified protein and fragments thereof are provided which have activity in inhibiting growth of oesophageal tumours.
PCT/US2002/039543 2001-12-12 2002-12-11 Therapeutic protein and nucleic acid WO2003054215A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002357145A AU2002357145A1 (en) 2001-12-12 2002-12-11 Therapeutic protein and nucleic acid

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN01138385A CN1425681A (en) 2001-12-12 2001-12-12 Protein and nucleic acid for therapy
CN01138385.2 2001-12-12

Publications (2)

Publication Number Publication Date
WO2003054215A2 WO2003054215A2 (en) 2003-07-03
WO2003054215A3 true WO2003054215A3 (en) 2005-03-17

Family

ID=4674581

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/039543 WO2003054215A2 (en) 2001-12-12 2002-12-11 Therapeutic protein and nucleic acid

Country Status (3)

Country Link
CN (1) CN1425681A (en)
AU (1) AU2002357145A1 (en)
WO (1) WO2003054215A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365391B1 (en) * 2000-09-27 2002-04-02 Pe Corporation (Ny) Isolated human serine protease, nucleic acid molecules encoding human serine protease, and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365391B1 (en) * 2000-09-27 2002-04-02 Pe Corporation (Ny) Isolated human serine protease, nucleic acid molecules encoding human serine protease, and uses thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
[online] 9 August 1999 (1999-08-09), accession no. NCBI Database accession no. (AQ80449) *

Also Published As

Publication number Publication date
AU2002357145A8 (en) 2003-07-09
CN1425681A (en) 2003-06-25
AU2002357145A1 (en) 2003-07-09
WO2003054215A2 (en) 2003-07-03

Similar Documents

Publication Publication Date Title
AU2002300450A1 (en) Collagen Carrier of Therapeutic Genetic Material, and Method
AU2002338529A1 (en) Biological pacemaker
AU2002346504A1 (en) Therapeutic protein and treatments
AU2002258728A1 (en) Gene brcc-3 and diagnostic and therapeutic uses thereof
AU2002305151A1 (en) Gene scc-112 and diagnostic and therapeutic uses thereof
AU2002303261A1 (en) Gene brcc2 and diagnostic and therapeutic uses thereof
AU2002365188A1 (en) Nucleic acid delivery and expression
AU2002316586A1 (en) Novel dna polymerases having amino acid substitutions and homologs thereof
WO2003054215A3 (en) Therapeutic protein and nucleic acid
AU2003279100A1 (en) Peptide nucleic acids having improved uptake and tissue distribution
WO2003080800A3 (en) Prevention and treatment of disease using angiogenesis-and/or tumor antigens
AU7846000A (en) Novel human lipase proteins, nucleic acids encoding them, and uses of both of these
AU2001292326A1 (en) Nucleic acid of novel human kinesin-associated gene, protein encoded by the nucleic acid, peptide fragment thereof and anticancer agents comprising the nucleic acid and the like
AU2003222378A8 (en) Combined dna vaccine and biological modifiers for cancer therapy
AU2002251367A1 (en) Proteins and genes for diagnosis and treatment of erbb2-related cancer
WO2001092524A3 (en) Myosin-like gene expressed in human heart and muscle
PL1670498T3 (en) p185 neu -ENCODING DNA AND THERAPEUTICAL USES THEREOF
AU2003273568A1 (en) Rb1 gene induced protein (rb1cc1) and gene
AU2001262108A1 (en) Non-physiologic dna fragments for tanning skin
AU2002322013A1 (en) Therapeutic dna vaccination
AU2002345407A1 (en) Human cervical cancer 5 protooncogene and protein encoded therein
AU2003263036A1 (en) SPAN-Xb GENE AND PROTEIN FOR THE DIAGNOSIS AND TREATMENT OF CANCER
AU2002953516A0 (en) Genetic therapy and genetic modification
EP1428877A4 (en) Novel protein and dna thereof
AU7304000A (en) Virulence gene and protein, and their use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP